Hangzhou Bio-Sincerity Pharma-Tech (301096.SZ): Employee strategic placement asset management plan proposes to reduce holdings by no more than 550,600 shares.

Hangzhou Bio-Sincerity Pharma-Tech (301096.SZ) announced that the company's shareholder, Fu Cheng Hai Fu Asset Management-Bank Of Hangzhou-Fu Cheng Hai Fu Tong, and employees of Hangzhou Bio-Sincerity Pharma-Tech will participate in the GEM strategic placement collective asset management plan (referred to as the "Employee Strategic Placement Asset Management Plan"). They plan to reduce their holdings of the company's shares by no more than 550,600 shares (0.5077% of the total share capital of the company) through block trading or centralized auction trading within 3 months after the date of this announcement, following a 15-day trading period.